Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

The PR shared some positive information about the phase 2 Brilacidin trial and the higher dose compassionate use

Will it be enough to qualify for the ACTIV trial? We will have to wait and see.

"Complete analysis of trial results already has begun, with the aim to potentially identify positive trends in the data that could support Brilacidin for inclusion in larger COVID-19 platform trials, such as the U.K.’s CTAP program and the NIH’s ACTIV program. The purpose of these programs is to prioritize development of promising COVID-19 therapeutics. Some COVID-19 drug candidates that did not meet their trial’s primary endpoint, for example Relief Therapeutics’ aviptadil, or those that showed inconclusive results in early clinical testing (e.g., anti-IL-6 drugs), have later gone on to be included in larger platform trials based on deeper analysis of trial results.

The Company’s intent, should full analysis of the Brilacidin COVID-19 trial results yield promising data, is to submit Brilacidin for inclusion in these larger COVID-19 platforms. Sufficient intravenous Brilacidin drug supply is on hand to support further clinical testing of Brilacidin in COVID-19."

https://www.ipharminc.com/press-release/2021/11/12/innovation-pharmaceuticals-conducting-full-data-analysis-of-phase-2-brilacidin-covid-19-trial-results-to-support-brilacidins-potential-inclusion-in-government-sponsored-covid-19-trials

GLTA,

Farrell